The nuclear medicine market is transforming with new technologies and therapeutic approaches to fulfill the unmet needs of clinical diagnostics, imaging, and treatment of various diseases. The specialized area of radiology is booming owing to the rise in applications for early and precise detection of cancer, respiratory, cardiovascular, and bone diseases.
Nuclear medicine also referred to as radiopharmaceuticals, is extensively adopted as biomarkers. These biomarkers play a potential role in molecular imaging, determining the progress of diseases. Moreover, cancer progression and detection are highly supported by these biomarkers, making them a preferable option in the field of oncology. In addition, the favorable government strategies for rapid approvals of radiopharmaceutical manufacturing drive its market growth.
The global nuclear medicine market size was estimated at USD 10.02 billion in 2023 and is expected to grow at a compound annual growth rate of (CAGR) 11.8% from 2024 to 2030.
Access the Nuclear Medicine Market Size, Share & Trends Analysis Report 2024-2030, published by Grand View Research
The healthcare industry is changing with consistent research and development efforts undertaken by market manufacturers, paving the way for plenty of opportunities in this field. Pharmaceutical companies are focusing on launching new nuclear medicine techniques with lesser risks and higher accuracy, marking its prominence in the healthcare sector. The growing dominance of various chronic diseases among the population and the high adoption rate of the nuclear medicine approach by healthcare professionals boost the demand for these products in the market. Moreover, the rising academic research activities are bringing highly efficient and effective techniques, expanding the growth trajectory for these devices.
Potential Factors Contributing to the Growing Need for Nuclear Medicine in Healthcare
Technological Advancement: The constant advancement in nuclear imaging technologies, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), have improved their efficiency and accuracy, making them more accessible and reliable.
Aging Population: The rise in the aging population, coupled with the growing incidence of chronic diseases, including cardiovascular, cancer, respiratory, and bone diseases, contributes to the high demand for nuclear medicine for diagnostic and therapeutic purposes.
Personalized Medicine: The growing trend for personalized medicine offers treatment tailored to an individual’s characteristics. Such an approach necessitates the nuclear medicine approach to treat individuals with a personalized therapeutic approach effectively.
Order Your Sample Copy of the Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By End-use, By Region, And Segment Forecasts, 2024 – 2030
Early and Accurate Diagnosis: Considering the emergence of various chronic diseases, there is a high need for accurate and early detection techniques for the right diagnosis and prevention of diseases. Nuclear medicine plays a significant role in tracing the diseased condition with radioactive molecules, serving as an efficient therapeutic option in clinical settings.
Favored Regulatory Approvals and Reimbursement: The regulatory authorities are supporting the nuclear medicine sector by providing rapid approvals along with favorable reimbursement policies, creating huge opportunities for innovation and product development in this sector.
Safety and Security: Nuclear medicine is not only an efficacious approach but also gives full-proof safety over other imaging techniques which increases its popularity among healthcare professionals.
Rising Public Awareness and Education: With the rise in the educational and awareness programs conducted by healthcare professionals and government bodies, nuclear medicine is gaining so much popularity. Such initiatives further increase its demand in the market.
These factors are significantly driving nuclear medicine prospects worldwide, specifying its importance and need in the healthcare domain. Moreover, constant research and development activities are expected to bring newer approaches to the well-being of people.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
